Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | MMP2 | P08253 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28718642 | 1.00 | SHBG (0.44) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL1193486 | 1.00 | SHBG (0.44) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL8582782 | 1.00 | SHBG (0.44) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL1193329 | 1.00 | SHBG (0.44) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL497976 | 0.97 | — | — | |
| SCHEMBL1193019 | 0.92 | — | — | |
| SCHEMBL910730 | 0.86 | — | — | |
| SCHEMBL5541917 | 0.80 | SHBG (0.41) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL20600327 | 0.80 | SHBG (0.41) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL5542043 | 0.80 | SHBG (0.41) | SHBGEPHX1TP53KDM4EGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106132913-A | Perfume systems | 宝洁公司 | 2016-11-16 | — | — | CN | claimed |
| US-5856556-A | Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics | SANKYO COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | claimed |
| WO-2024074641-A1 | METHOD FOR PREPARING AMIDES FROM ESTERS | BASF SE (DE) | 2024-04-11 | — | — | WO | disclosed |
| CN-110831681-B | Carboxamide for separating uranium (VI) and plutonium (IV) without reducing plutonium (IV) | 原子能和替代能源委员会 | 2021-11-19 | — | — | CN | disclosed |
| WO-2021219495-A1 | METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2021-11-04 | — | — | WO | disclosed |
| US-20210338626-A1 | METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2021-11-04 | — | — | US | disclosed |
| EP-3884019-A1 | HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-29 | — | — | EP | disclosed |
| CN-113227340-A | Home care compositions | 高露洁-棕榄公司 | 2021-08-06 | — | — | CN | disclosed |
| US-11008533-B2 | Home care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2021-05-18 | — | — | US | disclosed |
| US-20200208081-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | US | disclosed |
| WO-2020139335-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | WO | disclosed |
| CN-1034538-A | As useful diurea derivatives of medicine and preparation method thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1989-08-09 | — | — | CN | disclosed |
| EP-0102239-B1 | AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATES IN THE PREPARATION OF CARBAPENEM ANTIBIOTICS | SANKYO COMPANY LIMITED (JP) | 1987-10-14 | — | — | EP | disclosed |
| EP-0160391-A1 | Carbapenem derivatives and compositions containing them | SANKYO COMPANY LIMITED (JP) | 1985-11-06 | — | — | EP | disclosed |
| EP-0033928-B1 | USE OF ALKYL-SUBSTITUTED 1,3-DIOXOLANES AS PERFUMES, AND PERFUME COMPOSITIONS CONTAINING THEM | Henkel Kommanditgesellschaft auf Aktien (DE) | 1985-05-08 | — | — | EP | disclosed |
| EP-0102239-A1 | Azetidinone derivatives, a process for their preparation and their use as intermediates in the preparation of carbapenem antibiotics | SANKYO COMPANY LIMITED (JP) | 1984-03-07 | — | — | EP | disclosed |
| US-4435315-A | COSMETICS, DETERGENTS | HENKEL KOMMANDITGESELLSCHAFT AUF ATKIEN (DE) | 1984-03-06 | — | — | US | disclosed |
| EP-0033928-A2 | Use of alkyl-substituted 1,3-dioxolanes as perfumes, and perfume compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-08-19 | — | — | EP | disclosed |
| US-4136100-A | BLUE-VIOLET TO GREEN-BLUE DYEINGS ON CELLULOSE TEXTILES | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
| US-3936462-A | CNS DEPRESSANT, ANALGESIC | STERLING DRUG INC. (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210338626-A1 | METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION | ACE, ACE2, REN | SHBG 1695/4885EPHX1 3779/4885TP53 382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.